175 related articles for article (PubMed ID: 34641467)
1. Synthesis, Structural and Biological Properties of the Ring-A Sulfonamido Substituted Chalcones: A Review.
Mphahlele MJ
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641467
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Bioactivity of Reduced Chalcones Containing Sulfonamide Side Chains.
Noreljaleel AEM; Wilhelm A; Bonnet SL; van der Westhuizen JH
J Nat Prod; 2018 Jan; 81(1):41-48. PubMed ID: 29309141
[TBL] [Abstract][Full Text] [Related]
3. Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L
Expert Opin Ther Pat; 2015 Mar; 25(3):351-66. PubMed ID: 25598152
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating
Wu L; Yang Y; Wang Z; Wu X; Su F; Li M; Jing X; Han C
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150865
[TBL] [Abstract][Full Text] [Related]
6. Sulfonamide chalcones: Synthesis and in vitro exploration for therapeutic potential against Brugia malayi.
Bahekar SP; Hande SV; Agrawal NR; Chandak HS; Bhoj PS; Goswami K; Reddy MVR
Eur J Med Chem; 2016 Nov; 124():262-269. PubMed ID: 27592395
[TBL] [Abstract][Full Text] [Related]
7. Chemoselective regulation of TREK2 channel: activation by sulfonate chalcones and inhibition by sulfonamide chalcones.
Kim EJ; Ryu HW; Curtis-Long MJ; Han J; Kim JY; Cho JK; Kang D; Park KH
Bioorg Med Chem Lett; 2010 Jul; 20(14):4237-9. PubMed ID: 20570515
[TBL] [Abstract][Full Text] [Related]
8. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.
Maurya A; Agrawal A
Mini Rev Med Chem; 2024; 24(2):176-195. PubMed ID: 37497710
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of Antiplasmodial Activity of 2,2,2-Trifluoroethoxychalcones and 2-Fluoroethoxy Chalcones against Plasmodium falciparum in Culture.
Devi K; Rajendran V; ; Rangarajan TM; Singh RP; Ghosh PC; Singh M
Molecules; 2018 May; 23(5):. PubMed ID: 29757989
[TBL] [Abstract][Full Text] [Related]
11. Reinvestigation of structure-activity relationship of methoxylated chalcones as antimalarials: synthesis and evaluation of 2,4,5-trimethoxy substituted patterns as lead candidates derived from abundantly available natural β-asarone.
Kumar R; Mohanakrishnan D; Sharma A; Kaushik NK; Kalia K; Sinha AK; Sahal D
Eur J Med Chem; 2010 Nov; 45(11):5292-301. PubMed ID: 20863599
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents.
Bacharaju K; Jambula SR; Sivan S; Jyostnatangeda S; Manga V
Bioorg Med Chem Lett; 2012 May; 22(9):3274-7. PubMed ID: 22460028
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in therapeutic applications of chalcones.
Katsori AM; Hadjipavlou-Litina D
Expert Opin Ther Pat; 2011 Oct; 21(10):1575-96. PubMed ID: 21711087
[TBL] [Abstract][Full Text] [Related]
14. An in silico 3D pharmacophore model of chalcones useful in the design of novel antimalarial agents.
Bhattacharjee AK; Nichols DA; Gerena L; Roncal N; Gutteridge CE
Med Chem; 2007 Jul; 3(4):317-26. PubMed ID: 17627568
[TBL] [Abstract][Full Text] [Related]
15. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
16. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in biological aspects of chalcones: the odyssey continues.
Rani A; Anand A; Kumar K; Kumar V
Expert Opin Drug Discov; 2019 Mar; 14(3):249-288. PubMed ID: 30773996
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Fluorescence Properties of 4-Dialkylaminochalcones and Investigation of the Cytotoxic Mechanism of Chalcones.
Zhou B; Jiang P; Lu J; Xing C
Arch Pharm (Weinheim); 2016 Jul; 349(7):539-52. PubMed ID: 27214789
[TBL] [Abstract][Full Text] [Related]
19. Structural antitumoral activity relationships of synthetic chalcones.
Echeverria C; Santibañez JF; Donoso-Tauda O; Escobar CA; Ramirez-Tagle R
Int J Mol Sci; 2009 Jan; 10(1):221-231. PubMed ID: 19333443
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
